The multiple facets of drug resistance: one history, different approaches.
about
Overcome Cancer Cell Drug Resistance Using Natural ProductsDo relevant markers of cancer stem cells CD133 and Nestin indicate a poor prognosis in glioma patients? A systematic review and meta-analysisPatient-derived xenografts: a relevant preclinical model for drug developmentNew trends for overcoming ABCG2/BCRP-mediated resistance to cancer therapiesCell membrane modulation as adjuvant in cancer therapyRole of Curcumin in Common Musculoskeletal Disorders: a Review of Current Laboratory, Translational, and Clinical Data.Spheroids of HER2-Positive Breast Adenocarcinoma for Studying Anticancer Immunotoxins In Vitro.High glucose dephosphorylates serine 46 and inhibits p53 apoptotic activityGenomic analysis of drug resistant pancreatic cancer cell line by combining long non-coding RNA and mRNA expression profling.Increased HMGB1 and cleaved caspase-3 stimulate the proliferation of tumor cells and are correlated with the poor prognosis in colorectal cancer.Antitumor and antimetastatic activities of chloroform extract of medicinal mushroom Cordyceps taii in mouse models.The impact of insulin on chemotherapeutic sensitivity to 5-fluorouracil in gastric cancer cell lines SGC7901, MKN45 and MKN28.Dual targeting of microtubule and topoisomerase II by α-carboline derivative YCH337 for tumor proliferation and growth inhibition.The beneficial effect of Zinc(II) on low-dose chemotherapeutic sensitivity involves p53 activation in wild-type p53-carrying colorectal cancer cellsThe Development of an Angiogenic Protein "Signature" in Ovarian Cancer Ascites as a Tool for Biologic and Prognostic Profiling.Tivantinib induces G2/M arrest and apoptosis by disrupting tubulin polymerization in hepatocellular carcinoma.Effects of PI3K inhibitor NVP-BKM120 on overcoming drug resistance and eliminating cancer stem cells in human breast cancer cellsN-Hydroxyphthalimide exhibits antitumor activity by suppressing mTOR signaling pathway in BT-20 and LoVo cells.Inhibition of SALL4 reduces tumorigenicity involving epithelial-mesenchymal transition via Wnt/β-catenin pathway in esophageal squamous cell carcinoma.Enhanced therapeutic effect of an antiangiogenesis peptide on lung cancer in vivo combined with salmonella VNP20009 carrying a Sox2 shRNA constructSam68 reduces cisplatin-induced apoptosis in tongue carcinoma.PIM-1 contributes to the malignancy of pancreatic cancer and displays diagnostic and prognostic value.Growth differentiation factor 15 contributes to cancer-associated fibroblasts-mediated chemo-protection of AML cells.iASPP induces EMT and cisplatin resistance in human cervical cancer through miR-20a-FBXL5/BTG3 signaling.Understanding transporter specificity and the discrete appearance of channel-like gating domains in transporters.Annexin A2 could enhance multidrug resistance by regulating NF-κB signaling pathway in pediatric neuroblastoma.The kinase inhibitor D11 induces caspase-mediated cell death in cancer cells resistant to chemotherapeutic treatment.Cell death induction by the BH3 mimetic GX15-070 in thyroid carcinoma cellsAssociations of chemo- and radio-resistant phenotypes with the gap junction, adhesion and extracellular matrix in a three-dimensional culture model of soft sarcoma.Cell cycle synchronization and BrdU incorporation as a tool to study the possible selective elimination of ErbB1 gene in the micronuclei in A549 cells.Chromatin status of apoptosis genes correlates with sensitivity to chemo-, immune- and radiation therapy in colorectal cancer cell lines.Proton pump inhibitors (PPIs) impact on tumour cell survival, metastatic potential and chemotherapy resistance, and affect expression of resistance-relevant miRNAs in esophageal cancer.Proteins regulating the intercellular transfer and function of P-glycoprotein in multidrug-resistant cancer.Coupling to a cancer-selective heparan-sulfate-targeted branched peptide can by-pass breast cancer cell resistance to methotrexate.Reversal of drug-resistance by noscapine chemo-sensitization in docetaxel resistant triple negative breast cancer.A 35-gene signature discriminates between rapidly- and slowly-progressing glioblastoma multiforme and predicts survival in known subtypes of the cancer.High-throughput 3-dimensional culture of epithelial ovarian cancer cells as preclinical model of disease.
P2860
Q26784161-DDBAC865-441F-422F-A72D-5714A5BCE674Q26865791-EB3B0BDD-2477-441B-8814-F0CA61340596Q28067191-9BE17FBD-2523-4282-B703-498672EFD815Q28067499-70C610E5-AC42-4F2E-BAD9-98C002572E4AQ28078167-EB11FE3A-0E51-4BF4-A1C0-D742C4CF8BE2Q30989974-3EFFAE93-BE9C-4D13-828D-FCCF0998DFA4Q33607808-41F104B0-D264-4036-A570-C7B342B4C760Q34274477-0D287037-DE71-486B-914A-1D969FCB6376Q35145009-4E4BF3AD-E4E2-47AC-A1DC-3A05407C1BC3Q35658529-39664F5C-DE58-40A0-9719-8CBCFFEB49EAQ35686342-60ED2391-499A-4054-A28F-629198046F88Q35828140-3B512C65-B0B0-494E-87A8-499456C6C3A5Q35832271-C3D83109-D664-4380-92D0-AF4FB1CD707FQ35986990-777091AA-890C-4B60-81B8-52B309DEF569Q36039632-9779F17F-4E74-4887-BCE7-E9093ACAA6C4Q36156854-33949085-548F-49C8-BBB2-E63673BBE699Q36485168-26839EC8-5AE5-424D-970C-31A4627D6015Q36651651-BBEF89E6-2ECD-44AD-9F03-3B22203754DBQ37024249-103D9346-C5A3-4F24-9AFA-8D9AB67CD862Q37059663-B874FCB3-27BD-4A4E-BC6D-FD9F0482A176Q37138844-27AAE87C-0196-4EC6-9176-C02526BE9163Q37233255-53439424-B5F2-462B-A5AB-59CB391827CBQ37267749-3A279806-0A6C-4FAB-A522-E9D5F64BB92CQ37748056-7B133EC4-079F-4CF4-B8E2-21FAB95388A4Q38259553-016B7A0D-2892-4381-9D5D-6BF6399A48D6Q38621653-0B0543ED-015F-4CED-BE51-F25BA8745970Q38826790-779B4BF0-1AFA-41BA-8CF5-4569E5EC7CEBQ38850608-A807B62C-39CD-458C-A23A-936B61F17EF5Q38866042-58D3FBA9-836C-46D6-9FAD-81B56EDB2596Q38901267-78E8901C-BF96-4469-B9B2-EC538F7B8A56Q38949945-9E95A7F8-56BD-4E6E-9548-B1C496A055AAQ38961241-CC3B76D9-E079-469B-8C4A-E163F989BE0DQ47110047-B4CDBF1C-BB58-453A-9993-F717659CB87CQ47128720-47409BE0-225C-4293-B438-A10B0EB2089CQ47311101-C72960E8-FD7C-4B6A-85A8-762609691B43Q53698804-FC87D276-6F42-4854-B77B-39C8B2423CADQ55333460-21A66943-DFE4-4C9A-8884-BABA7BA5318A
P2860
The multiple facets of drug resistance: one history, different approaches.
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
The multiple facets of drug resistance: one history, different approaches.
@ast
The multiple facets of drug resistance: one history, different approaches.
@en
type
label
The multiple facets of drug resistance: one history, different approaches.
@ast
The multiple facets of drug resistance: one history, different approaches.
@en
prefLabel
The multiple facets of drug resistance: one history, different approaches.
@ast
The multiple facets of drug resistance: one history, different approaches.
@en
P2093
P2860
P921
P356
P1476
The multiple facets of drug resistance: one history, different approaches.
@en
P2093
Adam Arai Martens
Beatriz Araujo Cortez
Bianca Rocha-Sales
Camila Lauand
Evandro Luís Niero
Gláucia Maria Machado-Santelli
Jorge Henrique Neves
Marcel Shiniti Urabayashi
Marcelo Medina de Souza
Paula Rezende-Teixeira
P2860
P2888
P356
10.1186/1756-9966-33-37
P5008
P577
2014-04-28T00:00:00Z
P5875
P6179
1011425004